https://www.gosh.nhs.uk/news/planning-milestone-for-the-childrens-cancer-centre/
Planning milestone for the Children’s Cancer Centre
17 Apr 2023, 4:05 p.m.
With Camden Council providing the decision notice for the Children’s Cancer Centre, we have now been granted full planning permission for the scheme.
Designed with the needs of children at its heart, the Children’s Cancer Centre will have outdoor areas and spaces to play, so children can be active and do normal childhood activities. With cancer wards, cancer day care, new theatres and intensive care units co-located, specialist teams will be able to work more closely together and it will be quick and easy for children to access the services they need.
The building will also house new imaging equipment and a specialised chemotherapy pharmacy ensuring we at the forefront of world leading cancer care practice. Alongside the clinical services, the new building gives us the opportunity to create a new entrance for the hospital and to create a new school for the children who come to GOSH.
The new Children’s Cancer Centre will put us in a strong position to build on the decades of work undertaken by our clinicians and the researchers from our academic partner ICH to deliver the very best, kindest and effective treatments for cancer.
The Family Wall Project continues
Great Ormond Street Hospital Family Wall highlights complex mix of specialist care and all the teams involved in patient journeys.
Great Ormond Street Hospital for Children NHS Trust (GOSH) is looking for a new Non-Executive Director to focus on finance
Applications close on 17 October 2025.
Toddler who spent life in hospital is thriving after life-saving transplant
A family who spent the best part of 13 months in hospital praise their ‘new family’ at Great Ormond Street Hospital (GOSH), who cared for their son while he waited for a life-saving heart transplant.
Scientists discover clues to help children with rare muscle disease
New ground-breaking research by experts at Great Ormond Street Hospital (GOSH) and University College London (UCL) has led to an exciting discovery that could help children with the rare muscle disease, juvenile dermatomyositis (JDM).